HRP20030278B1 - Novel anticholinergic agents that can be used as medicaments and method for the production thereof - Google Patents

Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Info

Publication number
HRP20030278B1
HRP20030278B1 HR20030278A HRP20030278A HRP20030278B1 HR P20030278 B1 HRP20030278 B1 HR P20030278B1 HR 20030278 A HR20030278 A HR 20030278A HR P20030278 A HRP20030278 A HR P20030278A HR P20030278 B1 HRP20030278 B1 HR P20030278B1
Authority
HR
Croatia
Prior art keywords
fluorine
ethyl
methyl
medicaments
production
Prior art date
Application number
HR20030278A
Other languages
English (en)
Croatian (hr)
Inventor
Meissner Helmut
Morschh�user Gerd
Michael
Pohl Gerald
Reichl Richard
Speck Georg
Banholzer Rolf
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg.
Publication of HRP20030278A2 publication Critical patent/HRP20030278A2/hr
Publication of HRP20030278B1 publication Critical patent/HRP20030278B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
HR20030278A 2000-10-14 2003-04-11 Novel anticholinergic agents that can be used as medicaments and method for the production thereof HRP20030278B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050994A DE10050994A1 (de) 2000-10-14 2000-10-14 Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
PCT/EP2001/011226 WO2002032899A1 (de) 2000-10-14 2001-09-28 Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
HRP20030278A2 HRP20030278A2 (en) 2005-02-28
HRP20030278B1 true HRP20030278B1 (en) 2006-02-28

Family

ID=7659808

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030278A HRP20030278B1 (en) 2000-10-14 2003-04-11 Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Country Status (38)

Country Link
EP (2) EP1325001B1 (ko)
JP (2) JP4109106B2 (ko)
KR (1) KR100830359B1 (ko)
CN (1) CN1275962C (ko)
AR (1) AR035589A1 (ko)
AT (1) ATE259805T1 (ko)
AU (2) AU1397502A (ko)
BG (1) BG66225B1 (ko)
BR (1) BR0114635A (ko)
CA (1) CA2425557C (ko)
DE (2) DE10050994A1 (ko)
DK (1) DK1325001T3 (ko)
EA (1) EA005816B1 (ko)
EC (1) ECSP034542A (ko)
EE (1) EE05179B1 (ko)
ES (1) ES2215147T3 (ko)
HK (1) HK1060566A1 (ko)
HR (1) HRP20030278B1 (ko)
HU (1) HUP0301203A3 (ko)
IL (2) IL155334A0 (ko)
ME (1) MEP39908A (ko)
MX (1) MXPA03003160A (ko)
MY (1) MY127144A (ko)
NO (1) NO328207B1 (ko)
NZ (1) NZ525836A (ko)
PE (1) PE20020433A1 (ko)
PL (1) PL207311B1 (ko)
PT (1) PT1325001E (ko)
RS (1) RS50464B (ko)
SA (1) SA01220414B1 (ko)
SI (1) SI1325001T1 (ko)
SK (1) SK287138B6 (ko)
TR (1) TR200400376T4 (ko)
TW (1) TWI306098B (ko)
UA (1) UA73804C2 (ko)
UY (1) UY26958A1 (ko)
WO (1) WO2002032899A1 (ko)
ZA (1) ZA200302914B (ko)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10256317A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
CA2481468C (en) * 2002-04-12 2011-02-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments containing betamimetic drugs and a novel anticholinesterase drug
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
DE10216429A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
DE10224091A1 (de) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technisches Verfahren zur Herstellung von Tropenol
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE60310730T2 (de) * 2002-07-09 2007-05-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
DE10230750A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten
KR101060972B1 (ko) * 2002-08-14 2011-09-01 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 항콜린제를 함유하는 흡입용 에어로졸 제형
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
DE10323966A1 (de) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
US7332175B2 (en) 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
ATE420641T1 (de) * 2003-07-28 2009-01-15 Boehringer Ingelheim Int Medikamente zur inhalation mit betamimetika und einem anticholinergikum
DE602004021815D1 (de) * 2003-07-28 2009-08-13 Boehringer Ingelheim Pharma Medikamente zur inhalation mit steroiden und einem neuen fluorencarbonsäureester
CA2533786A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
WO2005013994A1 (en) * 2003-07-31 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising anticholinergics and a betamimetic
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
CA2547394A1 (en) * 2004-01-09 2005-07-28 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
JP2007523116A (ja) * 2004-02-20 2007-08-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬及びpegsunerceptを基にした新規な医薬組成物
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es) * 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
CA2597942A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol
JP2008532973A (ja) * 2005-03-09 2008-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とpde5−阻害剤に基づく新規な医薬組成物
WO2006128847A2 (en) * 2005-05-31 2006-12-07 Boehringer Ingelheim International Gmbh Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
JP2008543806A (ja) * 2005-06-17 2008-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療のためのmrpivインヒビター
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
MX2008001976A (es) 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
CA2626612A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
DE102005055961A1 (de) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
US20090324510A1 (en) 2006-08-07 2009-12-31 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
AU2008224541B2 (en) 2007-03-14 2013-08-22 Sun Pharmaceutical Industries Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
ES2569359T3 (es) 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhalador
WO2009010492A2 (en) * 2007-07-18 2009-01-22 Boehringer Ingelheim International Gmbh Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US9918995B2 (en) 2012-12-21 2018-03-20 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
CA2888431C (en) 2012-12-21 2021-10-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical formulation comprising ciclesonide
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
JP6559157B2 (ja) 2014-05-07 2019-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EA032832B1 (ru) 2014-05-07 2019-07-31 Бёрингер Ингельхайм Интернациональ Гмбх Небулайзер
LT3157522T (lt) 2014-06-18 2019-11-25 Boehringer Ingelheim Vetmedica Gmbh Muskarininiai antagonistai ir jų deriniai, skirti arklių kvėpavimo takų ligos gydymui
DK3344626T5 (da) * 2015-09-04 2021-09-06 Janssen Pharmaceutica Nv Terapeutiske forbindelser til smerte og syntese deraf
CN113292574B (zh) * 2020-02-21 2022-05-03 四川大学 一类手性多环的托品烷化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
PL207311B1 (pl) 2010-11-30
UA73804C2 (en) 2005-09-15
SI1325001T1 (en) 2004-08-31
NZ525836A (en) 2004-09-24
BG107688A (bg) 2003-09-30
NO20031693L (no) 2003-05-28
JP4109106B2 (ja) 2008-07-02
DK1325001T3 (da) 2004-06-21
DE10050994A1 (de) 2002-04-18
ES2215147T3 (es) 2004-10-01
JP2004511557A (ja) 2004-04-15
EP1325001A1 (de) 2003-07-09
KR20030041165A (ko) 2003-05-23
MEP39908A (en) 2011-02-10
WO2002032899A1 (de) 2002-04-25
EP1382606A3 (de) 2004-10-13
YU29503A (sh) 2006-03-03
ATE259805T1 (de) 2004-03-15
RS50464B (sr) 2010-03-02
SA01220414B1 (ar) 2007-01-20
IL155334A (en) 2009-02-11
PT1325001E (pt) 2004-07-30
ZA200302914B (en) 2003-11-14
JP2008120834A (ja) 2008-05-29
HRP20030278A2 (en) 2005-02-28
MXPA03003160A (es) 2005-09-09
HUP0301203A2 (hu) 2003-10-28
NO20031693D0 (no) 2003-04-11
EA200300459A1 (ru) 2003-10-30
EP1382606A2 (de) 2004-01-21
MY127144A (en) 2006-11-30
HUP0301203A3 (en) 2006-05-29
EE05179B1 (et) 2009-06-15
BG66225B1 (bg) 2012-06-29
EE200300151A (et) 2003-06-16
IL155334A0 (en) 2003-11-23
NO328207B1 (no) 2010-01-11
BR0114635A (pt) 2004-02-10
AU2002213975B2 (en) 2006-11-09
AU1397502A (en) 2002-04-29
EP1325001B1 (de) 2004-02-18
ECSP034542A (es) 2003-06-25
PE20020433A1 (es) 2002-06-28
SK4352003A3 (en) 2003-08-05
PL360673A1 (en) 2004-09-20
HK1060566A1 (en) 2004-08-13
KR100830359B1 (ko) 2008-05-20
CN1468236A (zh) 2004-01-14
CA2425557A1 (en) 2003-04-11
CA2425557C (en) 2007-11-13
EA005816B1 (ru) 2005-06-30
DE50101524D1 (de) 2004-03-25
SK287138B6 (sk) 2010-01-07
AR035589A1 (es) 2004-06-16
TR200400376T4 (tr) 2004-03-22
TWI306098B (en) 2009-02-11
CN1275962C (zh) 2006-09-20
UY26958A1 (es) 2002-06-20

Similar Documents

Publication Publication Date Title
HRP20030278B1 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
HRP20040690B1 (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
Bader et al. Nucleophilic displacements of activated fluorine in aromatic compounds
HRP20040977B1 (en) Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
HRP20020977B1 (en) Ortho-substituted anthranilic acid amides and their use as madicaments
CO4920234A1 (es) Derivados de acidos arilsulfonilaminomidroxamicos
AR041260A1 (es) Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia
RS50672B (sr) Postupak za pripremanje n-fenilpirazol-1-karboksamida
AR032676A1 (es) Quinazolinas como inhibidores de mmp-13
RS50537B (sr) Derivati benzimidazola i njihovo korišćenje kao antagonista receptora a ii
RS53061B (en) INHIBITORI PROTEIN KINAZE
RS50853B (sr) Derivati n-(1h-indolil)-1h-indol-2-karboksamida, njihova priprema i njihova primena u terapiji
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
ES2189251T3 (es) Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2&#39;.
AR078201A1 (es) Compuestos de 2-piridona y su uso en el tratamiento de enfermedades mediadas por la elastasa de neutrofilos
RU2009138136A (ru) Новый способ получения соединения 2-гидрокси-3-[5-(морфолин-4-илметил)пиридин-2-ил]1н-индол-5-карбонитрила 701
YU40998A (sh) Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
NO20080323L (no) Forbindelser og deres salter som er spesifikke overfor PPAR-reseptorer og EGF-reseptorer og deres anvendlse innen medisinen
NZ528997A (en) Sulfonamides
RS50676B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
RS51055B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja
PE20211549A1 (es) Compuestos meta-diamida para controlar plagas de invertebrados
RS20050806A (en) 4-substituted quinolein derivatives,preparation methods and intermediates and pharmaceutical compositions compraising same
AR037211A1 (es) Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120828

Year of fee payment: 12

PBON Lapse due to non-payment of renewal fee

Effective date: 20130928